06:38 AM EDT, 08/21/2025 (MT Newswires) -- BeOne Medicines ( ONC ) said Thursday that the European Commission has approved a new tablet version of Brukinsa for all existing indications.

The company said the new 160 mg film-coated tablets allow patients to take just two pills per day instead of four. The tablets are also smaller and easier to swallow than the original capsules, it added.

Brukinsa is used to treat certain blood cancers by blocking a protein that promotes the growth of cancerous B cells.